ICU Medical (NASDAQ:ICUI – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.
Analyst Recommendations
This is a summary of current ratings and recommmendations for ICU Medical and Innovative Eyewear, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ICU Medical | 0 | 3 | 4 | 2 | 2.89 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
ICU Medical presently has a consensus price target of $195.20, suggesting a potential upside of 10.10%. Given ICU Medical’s stronger consensus rating and higher possible upside, equities research analysts plainly believe ICU Medical is more favorable than Innovative Eyewear.
Institutional and Insider Ownership
96.1% of ICU Medical shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 1.8% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares ICU Medical and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ICU Medical | 2.76% | 8.40% | 4.51% |
| Innovative Eyewear | -216.76% | -102.66% | -92.20% |
Earnings and Valuation
This table compares ICU Medical and Innovative Eyewear”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ICU Medical | $2.23 billion | 1.99 | $730,000.00 | $2.39 | 74.18 |
| Innovative Eyewear | $2.66 million | 2.64 | -$7.59 million | ($1.18) | -0.68 |
ICU Medical has higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
ICU Medical has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.75, meaning that its share price is 175% more volatile than the S&P 500.
Summary
ICU Medical beats Innovative Eyewear on 12 of the 14 factors compared between the two stocks.
About ICU Medical
ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.
About Innovative Eyewear
Innovative Eyewear, Inc. is a technology and eyewear company that develops and sells smart glasses designed to combine traditional eyewear with wireless audio and hands-free digital functionality. Its products generally incorporate speakers, microphones and Bluetooth connectivity, allowing users to listen to music, make calls and interact with voice assistants while keeping their hands free. The company markets products under the Lucyd brand, including prescription-capable eyewear, sunglasses and blue-light-filtering styles.
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
